MedtronicXTER:2M6 +1.97%75 Operating Margin % is 20.53% as of Apr. 2026, which is 10% above its 10-year median of 18.73. GuruFocus rates XTER:2M6 with a GF Score™ of 75/100 and a GF Value™ of €86.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Medtronic ranks better than 83.95% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Medtronic's Operating Income for the
three
months ended in Apr. 2026 was €1,721 Mil. Medtronic's Revenue for the
three
months ended in Apr. 2026 was €8,385 Mil. Therefore, Medtronic's Operating Margin % for the quarter that ended in Apr. 2026 was 20.53%.
Good Sign:
Medtronic PLC operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Medtronic's Operating Margin % or its related term are showing as below:
XTER:2M6'
s Operating Margin % Range Over the Past 10 Years
Min: 16.25 Med: 18.73 Max: 21.7
Current: 18.78
XTER:2M6's Operating Margin % is ranked better than 83.95% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs XTER:2M6: 18.78
Medtronic's 5-Year Average Operating Margin % Growth Rate was 2.20% per year.
Medtronic's Operating Income for the
three
months ended in Apr. 2026 was €1,721 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Apr. 2026 was €5,840 Mil.
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Medtronic Operating Margin % Related Terms
Medtronic Operating Margin % Historical Data
* Premium members only.
The historical data trend for Medtronic's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:2M6 vs SYK, BSX, EW: Operating Margin % Comparison
For the Medical Devices subindustry, Medtronic's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medtronic Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medtronic's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Medtronic's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Medtronic's Operating Margin % for the fiscal year that ended in Apr. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medtronic (XTER:2M6) has a Operating Margin % of 20.53% as of Apr. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Medtronic and its competitors. This is 10% above median its historical median of 18.73. Over the past decade, Medtronic's Operating Margin % has ranged from 16.25 to 21.70. According to the industry distribution chart, Medtronic ranks #131 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 16.1%.
Is Medtronic's Operating Margin % too high?
Medtronic's current Operating Margin % of 20.53% is 10% above median its 10-year median of 18.73. Over the past 10 years, this metric has ranged from a low of 16.25 to a high of 21.70. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Medtronic's value of 20.53% is 492.5% above this industry median. Based on the distribution chart, Medtronic ranks #131 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medtronic has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medtronic's Operating Margin % compare to SYK and BSX?
According to the Medical Devices & Instruments industry distribution chart, Medtronic ranks #131 out of 816 companies for Operating Margin %. This places Medtronic in the top 16% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. Medtronic's value of 20.53% is 492.5% above this benchmark. Historically, Medtronic's own Operating Margin % has ranged from 16.25 to 21.70 over the past decade. While the company's 10-year median is 18.73 vs. the industry median of 3.47, Medtronic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medtronic's current Operating Margin % of 20.53% is 492.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Medtronic and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medtronic's current Operating Margin % is 20.53%, which is 10% above median its own 10-year median of 18.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medtronic stock overvalued right now?
Based on GuruFocus' analysis, Medtronic (XTER:2M6) is currently considered Modestly Undervalued. The stock's GF Value™ is €86.89, compared to a current price of €70.50 — trading 18.9% below its estimated fair value. The current Operating Margin % is 20.53%, which is 10% above median its 10-year median of 18.73 and 492.5% above the Medical Devices & Instruments industry median of 3.47. Medtronic's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Medtronic (XTER:2M6), the current Operating Margin % is 20.53% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medtronic (XTER:2M6) Overvalued in 2026?
Based on GuruFocus' analysis, Medtronic stock appears to be undervalued.
The current stock price of €70.50 is trading 18.9% below its estimated GF Value™ of €86.89.
GuruFocus considers Medtronic to be Modestly Undervalued.
Key valuation signals for XTER:2M6:
Operating Margin %: 20.53% (10% above median its 10-year median of 18.73)
GF Value™: €86.89 vs. price of €70.50 (18.9% below fair value)
Industry Position: 492.5% above the Medical Devices & Instruments median (#131 of 816)
No single metric tells the full story. See the XTER:2M6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
75GF Score
Get the complete analysis for XTER:2M6
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:2M6 has been successfully added to your 
